Cuprina Holdings
Singapore-based MedTech company that specialises in the development of products to treat chronic wounds. MEDIFLY, a bio-dressing made of live, medical-grade maggots, is used by private and public hospitals in Singapore and Hong Kong to disinfect and debride chronic wounds, known as Maggot Debridement Therapy (MDT). Our product is clinically-proven to reduce amputation rates and eliminate infections in chronic wounds, especially diabetic foot ulcers and pressure ulcers. We are ISO13485 certified and our MEDIFLY products are HSA registered as class C medical devices.
No more articles to show for this company
Resource Center
Awards
Apr
10
Events
Apr
09
Event News
Event News
Global medical innovations and AI-driven solutions in the spotlight
Medical Taiwan 2024 drew 280 exhibitors from 10 countries, boosting tech integration in healthcare.
Global medical innovations and AI-driven solutions in the spotlight
Medical Taiwan 2024 drew 280 exhibitors from 10 countries, boosting tech integration in healthcare.
Videos
Partner Sites
Join the community
Awards
Apr
10
Events
Apr
09